NCT00712712 2025-08-29
MEDOR
Institut Bergonié
Phase 2 Completed
Clinical Trials
10 trialsNCT00029029 2020-08-12
Radiofrequency Ablation in Relieving Pain in Patients With Bones Metastases
Mayo Clinic
Phase 2 Completed
NCT00024076 2020-08-03
Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer
Jonsson Comprehensive Cancer Center
Phase 2 Completed
NCT00004136 2018-11-06
Heat Therapy in Treating Patients With Unresectable Primary or Metastatic Liver Cancer
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00004142 2018-10-26
Radiofrequency Ablation Followed By Hepatic Artery Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00408772 2017-06-09
Oxaliplatin, Capecitabine, and Bevacizumab Followed By Surgery and/or Radiofrequency Ablation in Patients With Colorectal Cancer
University of California, Davis
Phase 2 Withdrawn
NCT00030563 2017-04-17
Surgery With or Without Radiofrequency Ablation Followed by Irinotecan in Treating Patients With Colorectal Cancer That is Metastatic to the Liver
University of Washington
Phase 2 Completed
NCT00019604 2017-02-03
Radiofrequency Ablation in Treating Patients With Unresectable Primary or Metastatic Liver Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Terminated
NCT00043004 2012-09-24
Chemotherapy and Bevacizumab With or Without Radiofrequency Ablation in Treating Unresectable Liver Metastases in Patients With Colorectal Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Terminated
NCT00180856 2005-09-16
Radiofrequency Ablation of Lung Tumors
Gustave Roussy, Cancer Campus, Grand Paris
Phase 2 Completed